Yan Shang

Yan Shang

Auto-generated profile, based on publicly available information

Yan Shang

School of Chemistry and Chemical Engineering, North Minzu University, Yinchuan 750021, P. R. China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2022 in Canadian Respiratory Journal
Verified
Journal Article
Open access
PDF file
JYJia-Ying Yuan
Jia-Ying Yuan
XWXiang-Yun Wang
Xiang-Yun Wang
ZTZhi-Ying Tong
Zhi-Ying Tong
YDYu-Chao Dong
Yu-Chao Dong
JZJiayi Zhao
Jiayi Zhao
YSYan Shang
Yan Shang
Asthma is a chronic inflammatory disturbance of the airways in which many cells and cellular elements are involved. Wheezing, breathlessness, chest tightness, and coughing, especially at night or in the early morning, are typical symptoms of asthma. At present, inhaled corticosteroid (ICS) and long-acting β-agonists (LABAs) are standard treatments for regular management. Oral corticosteroids (OCSs) were recommended for controlling asthma exacerbation but only for a short-term treatment because of the side effects on organs. Biologic therapies have achieved exciting and notable effects in clinical treatment but are not applicable for all phenotypes of asthma. At present, some new approaches are under exploration to lessen side effects and improve curative effects. Studies have revealed that bone marrow mesenchymal stem cells (BMMSCs) hold various curative effects in asthma and may benefit in the long term with high safety. Extracellular vesicles (EVs) enriched in body fluid were characterized as subcomponents of extracellular vesicles and delivered carriers combined with genetic messages in vivo. The therapeutic potential of exosomes has become a research hotspot in many diseases. BMMSC-derived exosomes were considered as the dominant part of BMMSCs in cell-to-cell communications and playing curative effects. Points also hold that BMMSC-Exo could interfere with airway inflammation and airway remolding in asthma via modulating the immune response, regulating gene expression, adjusting the phenotype of macrophage, etc. However, BMMSC-Exo still lacked more clinical trials for evaluating the effects on asthma, and the technology of extraction and purification still needs to be improved for wide use. This review aims to draw the relationship among asthma, BMMSC, and exosome, which may provide innovate ideas for treatment of asthma, and arouse attention about the curative potential of BMMSC-Exo.

14 August 2023 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
QLQian Li
Qian Li
JXJing Xu
Jing Xu
ZLZhenlu Liu
Zhenlu Liu
YSYan Shang
Yan Shang
ZLZezhong Li
Zezhong Li
YMYue Ma
Yue Ma
Amorphous bimetallic sulfide Co9S8/SnS2 is used as a p–n heterojunction to achieve photocatalytic hydrogen evolution.

27 July 2022 in Molecular Microbiology
Verified
Journal Article
Closed access
PLPeiwen Lv
Peiwen Lv
YLYaru Li
Yaru Li
RWRuimin Wang
Ruimin Wang
YZYe Zhang
Ye Zhang
WWWenkai Wang
Wenkai Wang
CYChunyu Yang
Chunyu Yang

4 August 2022 in Natural Product Communications
Verified
Journal Article
Open access
JYJiaying Yuan
Jiaying Yuan
YZYiqing Zhu
Yiqing Zhu
JZJiayi Zhao
Jiayi Zhao
LLLi Li
Li Li
CZChengjie Zhu
Chengjie Zhu
YSYan Shang
Yan Shang
Objectives: Coronavirus disease 2019 (COVID-19) has had a global impact and is spreading quickly. ChuanKeZhi injection (CKZI) is widely used in asthma patients. In this paper, we aimed to explore active compounds of CKZ and determine potential mechanisms against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through network pharmacology, molecular docking and dynamic simulation studies. Materials and Methods: We used the Systematic Pharmacology Database and Analysis Platform of Traditional Chinese Medicine (TCMSP) to screen active compounds and potential target proteins of CKZ. COVID-19 target genes were screened via the American National Center for Biotechnology Information (NCBI) gene database and human gene database (GeenCards). The protein interaction network was constructed by the Protein Interaction Network Database (Search Tool for the Retrieval of Interacting Genes/Proteins (STRING)) platform. GO enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed by the Metascape database. The main active compounds of CKZ were docked with angiotensin-converting enzyme 2 (ACE2), spike protein S1, and SARS-CoV-2-3CL pro and also docked with hub targets. We performed molecular dynamics (MD) simulation studies for validation. Results: We finally obtained 207 CKZ potential targets and 4681 potential COVID-19 targets. Key targets included mainly AKT1, TNF, IL6, VEGFA, IL1B, TP53, JUN, CASP3, etc. There were 217 Gene Ontology (GO) items in the GO enrichment analysis ( p < 0.05). The main KEGG pathways included the advanced glycation end products (AGE)- receptor for AGE (RAGE) signalling pathway in diabetic complications, rheumatoid arthritis, chemical carcinogenesis-receptor activation, alcoholic liver disease, etc. Molecular docking and dynamics simulation studies both exhibited great binding capacity. Conclusions: Network pharmacology, molecular docking and dynamics simulation studies were used to identify the potential and key targets, pharmacological functions, and therapeutic mechanisms of CKZI in the treatment of COVID-19. CKZI may be an effective and safe drug in COVID-19 treatment. However, further work is needed for validation.